AVO is the oversea subsidiary of Nanjing Synthgene Medtech Group. Based on the strong R&D capabilities and manufacturing capacity of its holding company, AVO is specialized in the development and production of in-vitro diagnostic materials and POCT reagents, well represented by its established technological platforms including protein expression and purification platforms, hybridoma monoclonal antibody screening platforms and antibody engineering design platforms etc. that are the essence of the development of diagnostic antibodies.

AVO’s manufacturing system meets GMP standards and is certified with ISO13854 by UKAS. Its in-vitro diagnostic reagent products are certified with the EU CE certification. AVO is also on the allow list for exporting the POCT kits of anti-epidemic products issued by Chinese Ministry of Commerce and has been highly recognized on the global markets ever since.

 Address: 1 Fusionopolis Place Level #03-20 Galaxis West Lobby Singapore 138522
 Tel: +65-68091155
 Sales mailbox：sales@avobiotech.com